XTX Topco Ltd Sells 14,782 Shares of Doximity, Inc. (NASDAQ:DOCS)

XTX Topco Ltd lessened its stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 53.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,988 shares of the company's stock after selling 14,782 shares during the period. XTX Topco Ltd's holdings in Doximity were worth $566,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its stake in shares of Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after buying an additional 603 shares in the last quarter. Blue Trust Inc. raised its position in Doximity by 621.4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company's stock worth $37,000 after purchasing an additional 1,193 shares in the last quarter. Quarry LP raised its position in Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company's stock worth $45,000 after purchasing an additional 131,253 shares in the last quarter. Morse Asset Management Inc bought a new position in Doximity during the third quarter worth about $46,000. Finally, First Horizon Advisors Inc. boosted its holdings in Doximity by 80.0% during the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company's stock valued at $48,000 after purchasing an additional 760 shares in the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Mizuho initiated coverage on Doximity in a report on Wednesday, December 4th. They issued a "neutral" rating and a $55.00 target price for the company. Evercore ISI increased their price objective on Doximity from $34.00 to $45.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. Morgan Stanley raised Doximity from an "underweight" rating to an "equal weight" rating and lifted their price objective for the company from $33.00 to $53.00 in a report on Thursday, November 14th. Baird R W raised shares of Doximity to a "strong-buy" rating in a report on Tuesday, September 17th. Finally, Bank of America lifted their price target on shares of Doximity from $32.00 to $45.00 and gave the company a "neutral" rating in a report on Monday, October 7th. Twelve research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $52.44.

Doximity Price Performance

Shares of NASDAQ DOCS traded down $0.56 during midday trading on Friday, hitting $52.14. The stock had a trading volume of 1,467,088 shares, compared to its average volume of 1,750,562. The firm has a market cap of $9.73 billion, a P/E ratio of 59.93, a price-to-earnings-growth ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75. The company's 50-day simple moving average is $48.05 and its 200 day simple moving average is $37.88.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.